Research suggests that metabolic reprogramming plays a role in the progression of certain cancers, including leukemia. The protein TRAF6 is implicated in leukemia progression through this process, while other proteins such as TRAF3 and SIRT2 may also contribute to metabolic reprogramming in various types of cancer cells. The specific mechanisms and pathways involved in these processes are being studied, with multiple signaling pathways and proteins potentially playing a role.